Difference between revisions of "PET Amyloid Biomarker Ctte"
Jump to navigation
Jump to search
m |
|||
Line 1: | Line 1: | ||
− | :Co-chairs: | + | :Co-chairs: Satoshi Minoshima, MD, PhD, Eric S. Perlman, MD, Anne M. Smith, PhD |
− | :Secretary: | + | |
+ | :Secretary: Julie Lisiecki | ||
:Roster: [[Media:QIBA PET-Amyloid Roster.pdf|(Roster)]] | :Roster: [[Media:QIBA PET-Amyloid Roster.pdf|(Roster)]] | ||
Revision as of 20:00, 27 May 2016
- Co-chairs: Satoshi Minoshima, MD, PhD, Eric S. Perlman, MD, Anne M. Smith, PhD
- Secretary: Julie Lisiecki
- Roster: (Roster)
Project Snapshot
There is a draft Profile, and current outline of the Claim is:
- SUVr will be the measurand
- The claim will have two components
- 1) Cross-sectional: single subject scan
- 2) Longitudinal: following subject over time
Due to the complexity of having multiple PET Amyloid tracers, a subgroup, the Test-retest Group, has been formed including academics and industry representatives from all of the major PET Amyloid tracer vendors. This group will evaluate the published data on amyloid imaging precision, to determine what level of precision can be claimed in the Profile. The committee’s goal is to have a final draft Profile by December, 2015.
Collaborations: RSNA QIBA is now an affiliate of GAAIN (Global Alzheimer’s Association International Network)
PET Amyloid Meetings/Call Summaries
PET Amyloid Profile Development
Profile Supporting Material
Working Documents
Reference Materials
Presentations and Reports: